The Phytochemistry International Research and Production Holding shared its favorable data on successfully promoted production technology of a new anti-paradontic agent based on pharmacologically active compounds of local plant materials and have released the product for use in dental practice. An agreement worth 95 million tenge was signed with QazInnovations in 2016. During the meeting in QazInnovations office, company representatives announced the results of project implementation using grant support and future plans. The achievements are of social and economic significance and contribute to population's health improvement and social well-being, which consists in providing it with an affordable, environmentally friendly means for prevention and treatment. The new domestic drug will expand the range of original drugs through the commercialization of research results. Currently, contracts have been concluded with pharmaceutical companies, a pharmacy chain and dental clinics. The market value of the drug is 2-2.5 times lower than foreign analogues.